Weight-loss drug may slow Alzheimer's decline
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
Aug 1, 2024
0
14
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
Aug 1, 2024
0
14
For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published ...
Jun 27, 2024
0
3
New research presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12–15 May), reveals the anti-inflammatory power of moderate-to-vigorous aerobic exercise in adults living with the low-grade inflammation ...
May 13, 2024
0
2
Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after bariatric surgery, a study led by UT Southwestern Medical Center researchers shows. The research ...
Jun 1, 2023
0
11
A new treatment for overweight and obesity combining the world's first and only procedure-free swallowable gastric balloon—that is placed without surgery, endoscopy or anesthesia and passes out of the body naturally after ...
May 16, 2023
0
12
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food ...
Sep 21, 2022
0
41
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...
Jan 21, 2022
0
50
Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular ...
Aug 4, 2021
0
420
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. However, where and how the drug acts in the brain was not fully understood, ...
Mar 4, 2020
0
42
Obesity increases a number of adverse health consequences including reduced health-related quality of life. But little is known about the relationship between weight loss and changes in quality of life.
Nov 6, 2019
0
2